Beyond The Numbers: 7 Analysts Discuss Corteva Stock
Across the recent three months, 7 analysts have shared their insights on Corteva (NYSE:CTVA), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 4 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 3 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $75.86, a high estimate of $80.00, and a low estimate of $70.00. This upward trend is apparent, with the current average reflecting a 2.71% increase from the previous average price target of $73.86.
Diving into Analyst Ratings: An In-Depth Exploration
The analysis of recent analyst actions sheds light on the perception of Corteva by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jeffrey Zekauskas | JP Morgan | Raises | Neutral | $77.00 | $75.00 |
| Kristen Owen | Oppenheimer | Raises | Outperform | $78.00 | $76.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $74.00 | $70.00 |
| Jeffrey Zekauskas | JP Morgan | Raises | Overweight | $75.00 | $70.00 |
| Edlain Rodriguez | Mizuho | Raises | Outperform | $80.00 | $78.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $70.00 | $68.00 |
| Richard Garchitorena | Wells Fargo | Lowers | Overweight | $77.00 | $80.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Corteva. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Corteva compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Corteva's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Corteva's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Corteva analyst ratings.
Delving into Corteva's Background
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
Key Indicators: Corteva's Financial Health
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Corteva displayed positive results in 3M. As of 31 December, 2025, the company achieved a solid revenue growth rate of approximately 49.35%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Corteva's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -14.12%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Corteva's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -2.24%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Corteva's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.3%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Corteva's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.11.
Analyst Ratings: What Are They?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.